Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FQWM9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,849
Award facts
- Contract value 100% obligated
- $32,848.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,848.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, issued on January 29, 2026, with an ultimate completion date of February 20, 2026, operates under a firm fixed-price structure with no set-aside designation, indicating the vendor competed in an unrestricted procurement environment. This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion acquisition strategy designed to establish multiple regional prime vendors supplying comprehensive pharmaceutical products to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its small business status and extensive product portfolio spanning branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The company's performance on numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division demonstrates its capability to fulfill the diverse pharmaceutical requirements of military healthcare operations. The Mirena delivery order exemplifies the recurring medical supply needs that the broader PPV-G GEN V contract structure supports, enabling efficient procurement of specialized pharmaceutical products to sustain Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FQWM9?
SPE2DR26FQWM9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FQWM9 worth?
The government has obligated $32,849 on SPE2DR26FQWM9.
Is contract SPE2DR26FQWM9 an order under another contract?
Yes. SPE2DR26FQWM9 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWM9 competed?
The extent of competition for SPE2DR26FQWM9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award